These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29179454)

  • 21. MicroRNA Expression Signature in Degenerative Aortic Stenosis.
    Shi J; Liu H; Wang H; Kong X
    Biomed Res Int; 2016; 2016():4682172. PubMed ID: 27579316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
    Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
    Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.
    Dong R; Shen Z; Zheng C; Chen G; Zheng S
    Sci Rep; 2016 Feb; 6():21084. PubMed ID: 26879603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potential microRNAs and their targets in promoting gefitinib resistance by integrative network analysis.
    Zheng F; Zhang H; Lu J
    J Thorac Dis; 2019 Dec; 11(12):5535-5546. PubMed ID: 32030273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the Interaction Network of Hub miRNAs-Hub Genes, Being Involved in Idiopathic Pulmonary Fibers and Its Emerging Role in Non-small Cell Lung Cancer.
    Yu DH; Ruan XL; Huang JY; Liu XP; Ma HL; Chen C; Hu WD; Li S
    Front Genet; 2020; 11():302. PubMed ID: 32300359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.
    Zhao Q; Cao J; Wu YC; Liu X; Han J; Huang XC; Jiang LH; Hou XX; Mao WM; Ling ZQ
    Am J Cancer Res; 2015; 5(5):1692-705. PubMed ID: 26175938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A preliminary microarray assay of the miRNA expression signatures in buccal mucosa of oral submucous fibrosis patients.
    Chickooree D; Zhu K; Ram V; Wu HJ; He ZJ; Zhang S
    J Oral Pathol Med; 2016 Oct; 45(9):691-697. PubMed ID: 26991343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer.
    Jin X; Guan Y; Sheng H; Liu Y
    Oncotarget; 2017 Oct; 8(53):91270-91280. PubMed ID: 29207642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
    Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
    Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
    Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
    Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
    Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen.
    Ninomiya M; Kondo Y; Kimura O; Funayama R; Nagashima T; Kogure T; Morosawa T; Tanaka Y; Nakayama K; Shimosegawa T
    J Viral Hepat; 2016 May; 23(5):330-9. PubMed ID: 26924666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of microRNA expression profiles associated with human alcoholic cardiomyopathy.
    Jing L; Jin C; Lu Y; Huo P; Zhou L; Wang Y; Tian Y
    Cardiology; 2015; 130(4):223-33. PubMed ID: 25791397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the miRNA-mRNA regulatory network in multiple sclerosis.
    Yang Q; Pan W; Qian L
    Neurol Res; 2017 Feb; 39(2):142-151. PubMed ID: 27809691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells.
    Zhou DH; Wang X; Feng Q
    Nutr Cancer; 2014; 66(4):636-44. PubMed ID: 24712372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA Genetic Variants Alter Their Secondary Structure and Expression in Patients With RASopathies Syndromes.
    de Carvalho JB; de Morais GL; Vieira TCDS; Rabelo NC; Llerena JC; Gonzalez SMC; de Vasconcelos ATR
    Front Genet; 2019; 10():1144. PubMed ID: 31798637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.